Ferring’s Nocdurna Nixed By FDA Panel, But Gets Multiple Paths Forward

Advisory committee members recommend Ferring conduct new pre-approval study to demonstrate clinical meaningful benefit of nocturia treatment, offering up variety of possible study designs.